Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 74
  1. Jan 15, 2026 · 08:32 · BUX

    BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

    BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

    01
  2. Jan 15, 2026 · 08:02 · BIOV

    BioVaxys 1Q2026 R&D and Collaborative Activity

    BioVaxys 1Q2026 R&D and Collaborative Activity

    02
  3. Jan 15, 2026 · 07:30 · PRN

    Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO(TM)

    Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO(TM)

    03
  4. Jan 15, 2026 · 07:30 · MDNA

    Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook

    Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook

    04
  5. Jan 14, 2026 · 18:13 · PHRM

    Pharmather enters obesity market with PharmaPatch

    Pharmather enters obesity market with PharmaPatch

    05
  6. Jan 14, 2026 · 10:31 · VIVI

    Tempramed receives validation of payer ROI model

    Tempramed receives validation of payer ROI model

    06
  7. Jan 14, 2026 · 09:46 · AVCR

    HealthTab(TM) to Expand Across North East London

    HealthTab(TM) to Expand Across North East London

    07
  8. Jan 14, 2026 · 08:01 · PHRM

    PharmaTher Expands PharmaPatch(TM) Platform into GLP-1 for Obesity, Leveraging Its Ketamine and Psychedelic Patch Programs

    PharmaTher Expands PharmaPatch(TM) Platform into GLP-1 for Obesity, Leveraging Its Ketamine and Psychedelic Patch Programs

    08
  9. Jan 14, 2026 · 02:01 · VIVI

    TempraMed Receives Positive Response on Payor Reimbursement Model Driving Significant Return on Investment for Medical Payor Coverage

    TempraMed Receives Positive Response on Payor Reimbursement Model Driving Significant Return on Investment for Medical Payor Coverage

    09
  10. Jan 13, 2026 · 21:00 · BCT

    BriaCell Therapeutics Announces Pricing of $30 million Public Offering

    BriaCell Therapeutics Announces Pricing of $30 million Public Offering

    10
  11. Jan 13, 2026 · 20:39 · CNVI

    Conavi Medical closes $12-million public offering

    Conavi Medical closes $12-million public offering

    11
  12. Jan 13, 2026 · 20:26 · ADK

    Diagnos talks regulatory progress for CARA

    Diagnos talks regulatory progress for CARA

    12
  13. Jan 13, 2026 · 19:30 · AIAI

    Netramark arranges $3.5-million private placement

    Netramark arranges $3.5-million private placement

    13
  14. Jan 13, 2026 · 17:36 · BCT

    Briacell Therapeutics has success with Bria-OTS patient

    Briacell Therapeutics has success with Bria-OTS patient

    14
← Newer Older →